Summary: what to expect
Tirzepatide, the active ingredient in Mounjaro, is a generally well-tolerated medication. However, like all incretin receptor agonists, it can cause side effects, especially during the first weeks of treatment and during dose increases. Most of these effects are gastrointestinal in nature, mild to moderate in intensity, and tend to diminish over time as the body adapts to the medication.
In the SURMOUNT and SURPASS clinical trials, the most reported adverse effects were nausea, diarrhea, constipation, vomiting, and abdominal pain. The treatment discontinuation rate due to adverse effects was relatively low, between 4 and 7 percent depending on the dose, indicating that the vast majority of patients manage to tolerate the medication long-term with appropriate management strategies.
Common side effects
These are the effects experienced by more than 5 percent of patients according to data from the product information approved by the EMA:
Nausea (20-33% of patients)
Nausea is the most common side effect of tirzepatide and of all GLP-1 agonists in general. It usually appears during the first days after each injection and is more intense during the first weeks of treatment and each time the dose is increased. In most cases, nausea is mild and does not prevent normal daily activities.
Strategies to reduce nausea:
- Eat smaller, more frequent portions throughout the day.
- Avoid fatty, fried, spicy, or heavily seasoned foods.
- Do not lie down immediately after eating; wait at least 30 minutes.
- Ginger tea, peppermint candies, or water with lemon can relieve mild nausea.
- Eat bland, warm foods on the days following the injection: rice, grilled chicken, toast, banana.
- If nausea is persistent, talk to your doctor about complementary anti-nausea medication.
Diarrhea (12-21%)
Diarrhea is the second most frequent effect. It is usually temporary and self-limiting, resolving within a few days. It is more common during the first weeks and during dose increases. In most cases, it does not require specific treatment beyond staying well hydrated.
If you experience frequent diarrhea, temporarily reduce the consumption of foods high in insoluble fiber, fats, and dairy. Drink plenty of water and oral rehydration solutions if necessary. Probiotics can help stabilize intestinal flora. If diarrhea is severe (more than 5 loose stools per day) or contains blood, consult your doctor immediately.
Constipation (6-11%)
Constipation may seem contradictory compared to diarrhea, but both are effects of the change in intestinal motility produced by tirzepatide. The slowing of gastric emptying that contributes to the feeling of fullness can also reduce the frequency of bowel movements.
To prevent and manage constipation, gradually increase your intake of soluble fiber through fruits, vegetables, and legumes. Drink at least two liters of water per day. Regular exercise, even walking for 30 minutes, stimulates intestinal motility. A fiber supplement such as psyllium can help if diet alone is not sufficient. Avoid stimulant laxatives without medical supervision.
Vomiting (5-9%)
Vomiting is less frequent than nausea but can occur, especially if you eat too quickly, too much, or very fatty foods after the injection. The key to preventing it is to respect the satiety signals that the medication amplifies: when you feel full, stop eating immediately, even if there is still food on your plate.
If you vomit within the first hours after the injection, do not administer an additional dose. The medication is rapidly absorbed after subcutaneous injection and is likely already in your bloodstream. If vomiting is frequent or prevents you from retaining fluids for more than 24 hours, contact your doctor.
Abdominal pain (5-8%)
Mild abdominal discomfort, especially in the upper abdomen, is relatively common and is usually related to the change in the rate of gastric emptying. Eating slowly, chewing well, and avoiding large meals helps minimize these discomforts.
Decreased appetite (very common)
Although technically this is the desired therapeutic effect, the reduction in appetite can be surprisingly intense for some patients, especially at the beginning. It is important not to stop eating completely: your body needs nutrients, especially protein, to maintain muscle mass and overall health. Plan small, nutritious meals even when you do not feel hungry.
Uncommon but important side effects
Hypoglycemia
Tirzepatide on its own has a low risk of hypoglycemia (dangerously low blood sugar levels). However, the risk increases significantly if combined with insulin or sulfonylureas. If you take any of these medications along with Mounjaro, your doctor will likely adjust their doses. Learn to recognize the symptoms of hypoglycemia: sweating, trembling, intense hunger, confusion, dizziness, and palpitations.
Injection site reactions
Some people experience redness, mild swelling, or itching at the injection site. These symptoms are usually mild and resolve within a few days. Rotating injection sites (abdomen, thigh, arm) each week helps prevent these reactions and lipodystrophy.
Increased heart rate
A mild increase in resting heart rate (2-4 beats per minute on average) has been observed with tirzepatide and other GLP-1 agonists. This effect is considered clinically insignificant for most patients, but should be monitored in people with pre-existing arrhythmias. Inform your doctor if you notice frequent or unusual palpitations.
Cholelithiasis (gallstones)
Rapid weight loss, regardless of the method, increases the risk of gallstone formation. This risk is not exclusive to tirzepatide but is associated with any significant weight loss. If you experience intense pain in the upper right abdomen, especially after fatty meals, consult your doctor to rule out biliary problems.
Rare but serious side effects
Pancreatitis
Very rare cases of acute pancreatitis have been reported with GLP-1 agonists. Symptoms include severe and persistent abdominal pain radiating to the back, and intense nausea and vomiting. If you experience these symptoms, discontinue the injection and go to the emergency room immediately. Tirzepatide is contraindicated in people with a history of pancreatitis.
Severe allergic reactions
Anaphylactic reactions are extremely rare. Symptoms include swelling of the face, lips, tongue, or throat, difficulty breathing, generalized hives, and a drop in blood pressure. Seek emergency medical attention if you experience any of these symptoms after an injection.
Thyroid problems
In animal studies, thyroid C-cell tumors were observed with GLP-1 receptor agonists. This effect has not been confirmed in humans, but as a precaution, tirzepatide is contraindicated in people with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 (MEN 2). Inform your doctor if you notice a lump or swelling in the neck, persistent hoarseness, or difficulty swallowing.
How side effects evolve over time
The good news is that most gastrointestinal side effects improve significantly over time. The body progressively adapts to the medication, and what may seem difficult to tolerate during the first weeks usually becomes barely noticeable by the second or third month of treatment.
The progressive titration schedule (starting with the lowest dose of 2.5 mg and increasing every 4 weeks) is designed precisely to minimize side effects. Each dose level acts as an adaptation period. Skipping levels or accelerating titration significantly increases the likelihood and intensity of adverse effects.
If side effects are particularly bothersome during a dose increase, talk to your doctor before the next escalation. It is possible to maintain an intermediate dose for a longer period or even temporarily return to the previous dose while your body adapts. The key is finding the balance between therapeutic efficacy and individual tolerability.
When to contact your doctor
Contact your doctor if you experience:
- Nausea or vomiting that does not improve after the first 2-3 weeks on a stable dose.
- Inability to retain fluids for more than 24 hours.
- Excessively rapid weight loss (more than 1.5 kg per week sustained over time).
- Signs of dehydration: very dark urine, dizziness when standing up, very dry mouth.
- Severe or persistent abdominal pain, especially if it radiates to the back.
- Sudden visual changes.
- Symptoms of hypoglycemia if combining with insulin or sulfonylureas.
- Any allergic reaction: facial swelling, difficulty breathing, hives.
Frequently asked questions about side effects
Do side effects mean the medication is not right for me?
Not necessarily. Mild gastrointestinal effects during the first weeks are a normal response of the body to the medication and do not indicate intolerance. Most patients who experience initial side effects manage to tolerate them well long-term. Only if the effects are severe, persistent, or interfere with your normal life should you discuss a change in strategy with your doctor.
Can I take anti-nausea medication along with Mounjaro?
Yes, your doctor may prescribe anti-nausea medication such as metoclopramide or ondansetron if nausea is particularly bothersome. There are also over-the-counter options such as dimenhydrinate. Always consult your doctor before taking any additional medication to ensure there are no interactions.
Are side effects worse with higher doses?
The incidence of gastrointestinal side effects tends to increase slightly with higher doses, but the relationship is not linear. Many patients who tolerate low doses well also tolerate high doses well, as the adaptation period at each level prepares the body for the next one. Gradual titration is the key to minimizing effects at each step.
Are the effects the same for everyone?
No. The response to tirzepatide is highly individual. Some people experience virtually no side effects, while others need more adaptation time. Factors such as diet, physical activity level, other medications being taken, and individual predisposition influence tolerability. Do not compare your experience with that of other patients.
Is it normal to lose your appetite almost completely?
A significant reduction in appetite is the expected therapeutic effect, but if it is so intense that it prevents you from eating for days or you lose weight too rapidly, consult your doctor. It is important to maintain a minimum intake of nutrients, especially protein, even when you do not feel hungry. Plan small, nutritious meals at regular intervals.